CBS 2019
CBSMD教育中心
中 文

双重抗血小板治疗持续时间

Abstract

Recommended Article

Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting - A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI

Guideline2018 Sep 24;46(9):680-694.

JOURNAL:中华心血管病杂志 Article Link

稳定性冠心病诊断与治疗指南

中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. Keywords: Angina pectoris; Coronary revascularization; Guidelines; Myocardial ischaemia; Risk factors; Stable coronary artery disease; anti-ischaemic drugs

摘要

2007年由中华医学会心血管病学分会多位专家组成的联合委员会制订的"慢性稳定性心绞痛诊断与治疗指南",充分采用中国人群流行病学和临床研究证据、结合国外研究结果及指南建议,对我国稳定性冠心病(stable coronary artery disease,SCAD)的防治工作起到了重要的指导作用。近10年来,由于循证医学证据的持续更新,对于SCAD病理生理机制的认识、疾病的诊断方法及治疗手段有了更加深入的理解。为此,中华医学会心血管病学分会介入心脏病学组、动脉粥样硬化与冠心病学组、中国医师协会心血管内科医师分会血栓防治专业委员会及中华心血管病杂志编辑委员会组织专家组,在近年发布的新技术和新药物临床应用循证证据的基础上,参考国内外指南,结合我国实际情况,对2007版指南进行了内容更新,为我国SCAD患者的诊治提供依据和原则,帮助临床医生做出医疗决策。